Loading...
•
Jun 30, 2022
Cencora Q3 2022 Earnings Report
AmerisourceBergen's revenue increased by 12.5% year-over-year, with GAAP diluted EPS of $1.92 and adjusted diluted EPS of $2.62.
Key Takeaways
AmerisourceBergen reported a strong third quarter with revenue increasing by 12.5% year-over-year to $60.1 billion. The company raised its full year outlook for adjusted diluted EPS to a range of $10.90 to $11.10.
Revenue increased 12.5 percent year-over-year to $60.1 billion.
GAAP diluted EPS was $1.92, compared to $1.40 in the prior year quarter.
Adjusted diluted EPS increased 21.3 percent to $2.62 from $2.16 in the prior year quarter.
Adjusted diluted EPS guidance has been raised to a range of $10.90 to $11.10 for fiscal year 2022.
Forward Guidance
AmerisourceBergen is updating its fiscal year 2022 financial guidance to reflect the stronger than expected performance of several of its businesses and a lower average diluted share count.
Positive Outlook
- Adjusted Diluted Earnings Per Share to be in the range of $10.90 to $11.10, raised from the previous range of $10.80 to $11.05.
- U.S. Healthcare Solutions operating income to be in the range of $2.44 billion to $2.48 billion, representing growth of 8% to 10%, raising the lower end of the previous range of $2.42 billion to $2.48 billion
- Weighted average diluted shares to be in the range of 211 million to 211.5 million shares for the fiscal year, lowered from the previous range of approximately 212 million shares
- Adjusted free cash flow to be in the range of $2.3 billion to $2.5 billion, raising the lower end of the previous range of $2.0 billion to $2.5 billion.
- All other previously communicated aspects of the Company's fiscal year 2022 financial guidance and assumptions remain the same.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...